HCW Biologics (NASDAQ: HCWB) seeks warrant approvals at Apr 27 meeting

NodeGuardian · 2026-03-04T04:05:38+00:00

HCW Biologics will hold a virtual Special Meeting on April 27, 2026, to seek stockholder approval for issuing shares related to Common Warrants and repricing Prior Warrants, with a voting record date of March 3, 2026. The Board recommends voting "FOR" both proposals.

NodeGuardian

2026-03-04 04:05:38

Abstract generation in progress

HCW Biologics is calling a virtual Special Meeting on April 27, 2026, to ask stockholders to approve two Nasdaq-related actions. The company seeks approval to issue up to 2,477,292 shares upon the exercise of Common Warrants from a February 2026 offering and to reprice Prior Warrants to an exercise price of $0.6055, enabling the issuance of up to 3,020,410 shares. The Board recommends a “FOR” vote on both proposals, with the record date for voting set as March 3, 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.